Discovery of 4-aminoindole carboxamide derivatives to curtail alpha-synuclein and tau isoform 2N4R oligomer formation

Discovery of 4-aminoindole carboxamide derivatives to curtail alpha-synuclein and tau isoform 2N4R oligomer formation

Alzheimer’s disease (AD) is a multifactorial, chronic neurodegenerative disease characterized by the presence of extracellular β-amyloid (Aβ) plaques, intraneuronal neurofibrillary tangles (NFTs), activated microglial cells, and an inflammatory state (involving reactive oxygen species production) in...

Full description

Bibliographic Details
Main Authors:	Eduardo Ramirez, Sehong Min, Susantha K. Ganegamage, Kazuma Shimanaka, Magaly Guzman Sosa, Ulf Dettmer, Jean-Christophe Rochet, Jessica S. Fortin
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Results in Chemistry
Subjects:	Alzheimer’s disease Amide Alpha-synuclein Fibril Oligomer Tau isoform 2N4R
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211715623001777

Similar Items

Characterization of α-synuclein oligomers formed in the presence of lipid vesicles
by: Anvesh K.R. Dasari, et al.
Published: (2024-07-01)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions
by: Je Min Yoo, et al.
Published: (2022-08-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

Correlations of erythrocytic oligomer α-synuclein levels with age, sex and clinical variables in patients with Parkinson’s disease
by: Zhe Lu, et al.
Published: (2024-07-01)

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils
by: S. Ekmark-Lewén, et al.
Published: (2023-01-01)

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
by: Catherine K. Xu, et al.
Published: (2022-02-01)

Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
by: Fabiana Miraglia, et al.
Published: (2020-08-01)

Oligomer technology and applications /
by: 247586 Uglea, Constantin V.
Published: (1998)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
by: Cecilia Chavarría, et al.
Published: (2022-04-01)

Reduction of alpha-synuclein oligomers in preclinical models of Parkinson’s disease by electrical stimulation in vitro and deep brain stimulation in vivo
by: Eun Jung Lee, et al.
Published: (2024-03-01)

Oligomerization by co-assembly of β-amyloid and α-synuclein
by: Jin Ryoun Kim
Published: (2023-03-01)

α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
by: Emmanouela Leandrou, et al.
Published: (2024-02-01)

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein
by: Ebrima Gibbs, et al.
Published: (2022-09-01)

Metal interactions of α-synuclein probed by NMR amide-proton exchange
by: Mario Gonzalez-Garcia, et al.
Published: (2023-05-01)

1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α‑Synuclein Oligomer Formation In Vitro
by: Susantha K. Ganegamage, et al.
Published: (2023-12-01)

Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation
by: Marco Giampà, et al.
Published: (2021-12-01)

A rapid, semi-quantitative assay to screen for modulators of alpha-synuclein oligomerization ex vivo
by: Marion eDelenclos, et al.
Published: (2016-01-01)

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease
by: Paul Anthony Martinez, et al.
Published: (2023-09-01)

Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy
by: Alessandra Bigi, et al.
Published: (2021-05-01)

The Synucleins and the Astrocyte
by: Abigail J. Myers, et al.
Published: (2023-01-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
by: Martin Muschol, et al.
Published: (2023-02-01)

Characteristics of tau oligomers
by: Yan eRen, et al.
Published: (2013-07-01)

Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
by: Louise Berkhoudt Lassen, et al.
Published: (2022-11-01)

Oligomers, polymer composites, molecular imprinting /
by: Boutevin, Bernard
Published: (2007)

Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
by: Shenjie Wu, et al.
Published: (2023-01-01)

Controlled reduction of carboxamides to alcohols or amines by zinc hydrides
by: Ong, Derek Yiren, et al.
Published: (2020)

Tau Oligomers Neurotoxicity
by: Grazyna Niewiadomska, et al.
Published: (2021-01-01)

Peptidylglycine monooxygenase activity of monomeric species of growth hormone
by: John Donlon, et al.
Published: (2019-09-01)

Improving the Photoconductivity of a Fullerene-Based Oligomer with Polythiophenes
by: André V. S. Simõis, et al.
Published: (2025-02-01)

Update on Phytochemistry and Pharmacology of Naturally Occurring Resveratrol Oligomers
by: Jie Shen, et al.
Published: (2017-11-01)

Dopamine prevents lipid peroxidation-induced accumulation of toxic α-synuclein oligomers by preserving autophagy-lysosomal function
by: Peizhou eJiang, et al.
Published: (2013-05-01)

α-Synuclein Oligomer Detection with Aptamer Switch on Reduced Graphene Oxide Electrode
by: Seung Joo Jang, et al.
Published: (2020-04-01)

DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein
by: Tamr B. Atieh, et al.
Published: (2021-10-01)

Mechanistic insights on reduction of carboxamides by diisobutylaluminum hydride and sodium hydride−iodide composite
by: Ong, Derek Yiren, et al.
Published: (2022)

Detection of elevated levels of PINK1 in plasma from patients with idiopathic Parkinson’s disease
by: Xianchai Hong, et al.
Published: (2024-04-01)

Monitoring of Microplastics and Styrene Oligomers in the Atmosphere
by: Bum Gun Kwon
Published: (2022-12-01)

Discovery of antiplasmodial pyridine carboxamides and thiocarboxamides
by: Alexa Redway, et al.
Published: (2024-08-01)